Bayer (ETR:BAYN) target price raised to 110.00EUR, reported today by Commerzbank AG
- Updated: September 16, 2016
Having a price of 91.44EUR, Bayer (ETR:BAYN) traded 0.00% even on the day. The last close is up 1.82% relative to the 200-day average, compared to the S&P 500 which has decreased -0.01% over the same period. BAYN has recorded a 50-day average of 0.04EUR and 200-day average of 0.03EUR. 0 shares of BAYN traded, down from ann average volume of 211
Commerzbank AG bumped the target price of Bayer (ETR:BAYN) to 110EUR, indicating a possible upside of 0.20%,
On 8/29/2016, Citigroup Corp. reported about Bayer(ETR:BAYN) raised the target price from 0.00EUR to 120.00EUR that suggested an upside of 0.24%.
Bayer has a 52 week low of 0.03EUR and a 52 week high of 0.04EUR and has a total market value of 0.0 EUR.
More About Bayer (ETR:BAYN)
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development of over-the-counter medications, dermatology products and nutritional supplements. The Crop Science segment is engaged in the development of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Animal Health segment is engaged in the development of veterinary medicines and animal grooming products. Covestro is engaged in the development of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, and adhesives and sealants; and selected chemical intermediates.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.